134 related articles for article (PubMed ID: 37743679)
1. Comparison of the Effectiveness and Safety of Clozapine Between Once-Daily and Divided Dosing Regimen in Patients With Treatment-Resistant Schizophrenia.
Sathienluckana T; Jansing T; Srisuriyakamon S; Thonkhunthod A; Sangsuwanto P; Losatiankij P; Supanya S
Ann Pharmacother; 2024 Jun; 58(6):598-604. PubMed ID: 37743679
[TBL] [Abstract][Full Text] [Related]
2. Clozapine administration in clinical practice: once-daily versus divided dosing.
Takeuchi H; Powell V; Geisler S; DeSanti M; Fervaha G; Agid O; Kane JM; Remington G
Acta Psychiatr Scand; 2016 Sep; 134(3):234-40. PubMed ID: 27182769
[TBL] [Abstract][Full Text] [Related]
3. Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis.
Kuzo N; Haen E; Ho DM; Takeuchi H; Piras M; Eap CB; de Filippis R; Homan P; Kane JM; Roy MA; Paulzen M; Schoretsanitis G
Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1567-1578. PubMed ID: 36580106
[TBL] [Abstract][Full Text] [Related]
4. Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore.
Yang Z; Takeuchi H; Yee JY; See YM; Tang C; Ng BT; Lee J
Schizophr Res; 2023 Oct; ():. PubMed ID: 37833207
[TBL] [Abstract][Full Text] [Related]
5. Clozapine Once-Daily Versus Divided Dosing Regimen: A Cross-sectional Study in Japan.
Kitagawa K; So R; Nomura N; Tsukahara M; Misawa F; Kodama M; Uchida H; Bies R; Straubinger T; Banker C; Mizuno Y; Mimura M; Takeuchi H
J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):163-168. PubMed ID: 34879387
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
Meltzer HY; Bobo WV; Roy A; Jayathilake K; Chen Y; Ertugrul A; Anil Yağcioğlu AE; Small JG
J Clin Psychiatry; 2008 Feb; 69(2):274-85. PubMed ID: 18232726
[TBL] [Abstract][Full Text] [Related]
7. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.
Miodownik C; Lerner V; Kibari A; Toder D; Cohen H
J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197
[TBL] [Abstract][Full Text] [Related]
8. Clinical Utility and Safety of Slower-than-Recommended Titration of Clozapine for Treatment-Resistant Schizophrenia: a Retrospective Cohort Study.
Tsukahara M; So R; Yada Y; Kodama M; Kishi Y
Psychiatr Q; 2021 Jun; 92(2):703-713. PubMed ID: 32889690
[TBL] [Abstract][Full Text] [Related]
9. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics.
Stam N; Taipale H; Tanskanen A; Isphording L; Okhuijsen-Pfeifer C; Schuiling-Veninga CCM; Bos JHJ; Bijker BJ; Tiihonen J; Luykx JJ
Clin Transl Sci; 2020 Nov; 13(6):1170-1177. PubMed ID: 32441836
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of different dosing regimens of risperidone and olanzapine in schizophrenia.
Takeuchi H; Fervaha G; Lee J; Agid O; Remington G
Eur Neuropsychopharmacol; 2015 Mar; 25(3):295-302. PubMed ID: 25649680
[TBL] [Abstract][Full Text] [Related]
11. Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
Masuda T; Misawa F; Takase M; Kane JM; Correll CU
JAMA Psychiatry; 2019 Oct; 76(10):1052-1062. PubMed ID: 31365048
[TBL] [Abstract][Full Text] [Related]
12. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Béchard L; Corbeil O; Plante M; Thivierge MA; Lafrenière CÉ; Roy MA; Demers MF
J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529
[TBL] [Abstract][Full Text] [Related]
13. Impact of once- versus twice-daily perphenazine dosing on clinical outcomes: an analysis of the CATIE data.
Takeuchi H; Fervaha G; Uchida H; Suzuki T; Bies RR; Grönte D; Remington G
J Clin Psychiatry; 2014 May; 75(5):506-11. PubMed ID: 24569099
[TBL] [Abstract][Full Text] [Related]
14. Effects on monotherapy and reduction of antipsychotic drugs by clozapine therapy in Japanese patients with treatment-resistant schizophrenia.
Akamine Y; Kikuchi Y; Miura M
J Clin Pharm Ther; 2021 Oct; 46(5):1312-1318. PubMed ID: 33959995
[TBL] [Abstract][Full Text] [Related]
15. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone.
Still DJ; Dorson PG; Crismon ML; Pousson C
Psychiatr Serv; 1996 Dec; 47(12):1382-4. PubMed ID: 9117479
[TBL] [Abstract][Full Text] [Related]
16. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
[TBL] [Abstract][Full Text] [Related]
18. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
Cook B; Hoogenboom G
Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
[TBL] [Abstract][Full Text] [Related]
19. Effects of clozapine for non-treatment-resistant patients with schizophrenia.
Galletly CA; Clark CR; McFarlane AC; Weber DL
Psychiatr Serv; 1999 Jan; 50(1):101-3. PubMed ID: 9890589
[TBL] [Abstract][Full Text] [Related]
20. Beneficial Effects of Concomitant Long-Acting Injectable Antipsychotics on Time to Rehospitalization in Patients With Treatment-Resistant Schizophrenia Receiving Clozapine: A Retrospective Cohort Study.
Tien Y; Wang XY; Huang SC; Huang HP
J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38696112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
